HIV treatment: latest news

HIV treatment resources

HIV treatment features

HIV treatment in your own words

HIV treatment news from aidsmap

More news

HIV treatment news selected from other sources

  • ViiV Survey Reveals Nuances of Living With HIV

    Respondents reported on their feelings about antiretrovirals, their relationships with their clinicians and dealing with stigma.

    30 October 2017 | Poz
  • Viral Rebound Unlikely for Many on ART

    British investigators have determined that a substantial proportion of people with HIV who are taking antiretroviral therapy (ART) will not experience viral rebound during their lifetime.

    14 July 2017 | Infectious Disease Special Edition
  • HIV: A therapeutic advance for resource-limited settings

    ANRS 12286 MOBIDIP, a clinical trial running in parallel in three countries in sub-Saharan Africa, shows that dual therapy with lamivudine and a boosted protease inhibitor is effective as second-line treatment in patients infected by HIV with multiple mutations. Such treatment deescalation will reduce costs, side effects, and the need for virological monitoring of patients. The results of this study are published in The Lancet HIV.

    31 May 2017 | Eurekalert Inf Dis
  • The Truth About HIV

    Dr Chris van Tulleken explores the latest science around HIV, meeting health professionals, scientists, and individuals affected by it in the UK and South Africa.

    26 May 2017 | BBC iPlayer (UK only, available until 24 June)
  • Unexpected side effects with generic abacavir – and potential for rare reactions to other generic ARVs

    Several anecdotal reports of mouth ulcers have recently been reported in people switching to generic abacavir in the UK. This should highlight awareness of the potential of likely-rare new side effects, even when both formulations have been approved as bioequivalent.

    23 May 2017 | HIV i-Base
  • Should Antiretroviral Therapy be Offered the Same Day as Diagnosis?

    Andy Seale summarizes a discussion that took place on ITPC’s listserv about when to initiate antiretroviral therapy. The discussion included consideration of WHO’s recommendation for Same Day Start.

    23 March 2017 | ITPC
  • Clinical Commissioning Policy: Tenofovir Alafenamide for treatment of HIV 1 in adults and adolescents

    TAF containing products can be made available to patients who have defined renal or bone problems or who have medical reasons why they cannot take other HIV drugs.

    06 March 2017 | NHS England
  • 'Keeping the Foot on the Gas' of HIV Research at CROI 2017

    When controversies arise, researchers return to the science. So at the Conference on Retroviruses and Opportunistic Infections (CROI) 2017, which will convene next week amid funding concerns and boycotts, researchers will be diving deep into the evidence.

    08 February 2017 | Medscape (requires free registration)
  • Worried About HIV and Aging? The First Thing to Do Is Stop Smoking

    There are people out there who are anxious about the impact HIV has on the aging process, but who continue to smoke. This is to be preoccupied by a threat that we don't quite understand and are not sure how to deal with, while neglecting a very real health threat that can be changed and brought under control.

    12 January 2017 | The Body
  • British team studies initiation of treatment shortly after HIV diagnosis

    A team of researchers in London, England, has reviewed the medical records of 113 men whose acute HIV infection was diagnosed at a sexual health clinic. The team found that most of the men (77%) initiated ART at their first clinic visit. Furthermore, they found that 99% of participants had an undetectable viral load within six months of initiating ART.

    21 December 2016 | CATIE
More news

Our information levels explained

  • Short and simple introductions to key HIV topics, sometimes illustrated with pictures.
  • Expands on the previous level, but also written in easy-to-understand plain language.
  • More detailed information, likely to include medical and scientific language.
  • Detailed, comprehensive information, using medical and specialised language.
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.